Court examines osteoporosis drug lawsuit

In recent weeks, reports have shown that osteoporosis drugs known as bisphosphonates can cause bone breakage after extended use. Currently, the Manhattan Trial Court is examining a lawsuit filed by 1,400 people against Fosomax, an osteoporosis drug manufactured by Merck, Top News reports.

The court is examining the effects and side effects of this and other osteoporosis drugs to determine their relationship to patients developing brittle bones.

U.S. government health officials have warned doctors and patients of the possible side effects, and the Food and Drug Administration (FDA) stated that Fosomax may increase the risk of developing brittle bones. The FDA believes that fracturing may result from exposure to biphosphonates for periods exceeding five years, although the agency remains unclear about the direct effects of bisphosphonate drugs on bone fractures, according to the news source.



Fosomax is within the group of bisphosphonates that change the cycle of bone formation in the body. Studies have linked the drugs to thigh fractures, jaw impairments and fracturing.



Approximately eight million women and two million men have osteoporosis in the U.S., according to the National Osteoporosis Foundation. 
Last updated on
SHOW MAIN MENU
SHOW SUB MENU